OUH - News and Events
JITC Collections and Special Issues - Society for Immunotherapy of Cancer (SITC)
Journal for ImmunoTherapy of Cancer on X: "The Journal for ImmunoTherapy of Cancer (#JITC) increased its Impact Factor today to 9.913! Congratulations and THANK YOU to the editors, reviewers, authors and readers
Journal for ImmunoTherapy of Cancer (JITC) - YouTube
Journal for ImmunoTherapy of Cancer on LinkedIn: #aacr24 #jitc
Journal for ImmunoTherapy of Cancer | LinkedIn
Cancer immunotherapy | Nature
Journal for ImmunoTherapy of Cancer - review Template - BMC
Join us in congratulating Incoming Editor-in-Chief Michael Lotze and Deputy Editor-in-Chief Sjoerd van der Burg - Journal for ImmunoTherapy of Cancer - OncoDaily
Journal for ImmunoTherapy of Cancer - review Template - BMC
International Journal of Immunotherapy and Cancer Research
Journal for ImmunoTherapy of Cancer | Boltz Research
Journal for ImmunoTherapy of Cancer (JITC) - YouTube
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
Society for Immunotherapy of Cancer on X: "The @sitcancer and @jitcancer are pleased to announce Michael T. Lotze, MD as JITC's Incoming Editor-in-Chief. With over 30 years in the field, Dr. Lotze
Targeted immunotherapy could lead to pioneering treatment for breast cancer
Homepage | The Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
JITC Editorial Board - Society for Immunotherapy of Cancer (SITC)
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells - Immunomodulation Lab
About JITC - Society for Immunotherapy of Cancer (SITC)
The Results of Phase I Clinical Study of KN046 were published in Journal for ImmunoTherapy of Cancer-Alphamab Oncology
Journal for ImmunoTherapy of Cancer | LinkedIn
PDF) Moving cancer immunotherapy forward through the Journal for ImmunoTherapy of Cancer (JITC)
